AKT1 and neoplasm: α6β4 signaling in malignant cells cooperates with growth factor receptors and amplification of well-known tumor-promoting pathways, such as PI3K, AKT, and MAPK, thus resulting in, for example, proliferative signaling, tumor invasion, metastasis, evasion of apoptosis, and stimulation of angiogenesis.